Three things to know:
1. InVivo is a clinical-stage biomaterials and biotechnology company focusing on the treatment of spinal cord injuries.
2. Dr. Rosenthal serves as chairman of the board of Taconic Biosciences and director at Safeguard Scientifics and Galvanic Applied Sciences, among other leadership positions.
3. He has more than 25 years of experience in leadership positions and plans to advance InVivo’s “clinical pathway to ultimately address an … unmet need for spinal cord injury patients.”
More articles on devices:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.